Skip to main content
PRFX
NASDAQ Life Sciences

PRF-110 Preclinical Study Shows 72-Hour Pain Relief Comparable to Approved Benchmark

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.432
Mkt Cap
$1.258M
52W Low
$1.28
52W High
$17.95
52W Position info
12% above low
Off High info
92% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

PRFX is trading near its 52-week low of $1.28 (12% above the low) on light trading volume (0.2× avg).

Summary

PRF Technologies announced positive preclinical results for its lead product candidate, PRF-110, demonstrating sustained 72-hour analgesic activity comparable to the approved benchmark ZYNRELEF. PRF-110's ropivacaine-only, NSAID-free formulation also suggests a potential safety advantage with lower cardiac toxicity. This positive pipeline development is significant for the micro-cap company, especially following recent highly dilutive equity financing agreements in May. The results de-risk future development steps and could bolster investor confidence.

At the time of this announcement, PRFX was trading at $1.43 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3M. The 52-week trading range was $1.28 to $17.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

PRFX - Latest Insights

PRFX
Nov 05, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7588
Real-time Price: $0.7948 info
Change: +$0.036 (+5%) info
Market Cap: $2.424M info
PRFX
Nov 03, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.7705
Real-time Price: $0.7948 info
Change: +$0.0243 (+3%) info
Market Cap: $2.424M info
PRFX
Nov 03, 2026, 4:01 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.711
Real-time Price: $0.7948 info
Change: +$0.0838 (+12%) info
Market Cap: $2.424M info
PRFX
Sep 24, 2026, 4:15 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $1.07
Real-time Price: $0.7948 info
Change: -$0.2752 (-26%) info
Market Cap: $2.424M info
PRFX
Sep 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.945
Real-time Price: $0.7948 info
Change: -$0.1502 (-16%) info
Market Cap: $2.424M info